Published in J Drugs Dermatol on February 01, 2012
Cell death: apoptosis versus necrosis (review). Int J Oncol (2002) 2.20
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer (2013) 2.14
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS (2009) 1.25
Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol (2004) 1.18
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04
Modeling the bound conformation of Pemphigus vulgaris-associated peptides to MHC Class II DR and DQ alleles. Immunome Res (2006) 1.04
Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics (2010) 1.04
Oxidative stress and autoimmune skin disease. Eur J Dermatol (2013) 0.99
Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol (2006) 0.94
Clinical applications of DNA microarray analysis. J Exp Ther Oncol (2003) 0.93
Investigation of human keratinocyte cell adhesion using atomic force microscopy. Nanomedicine (2009) 0.92
Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity (2006) 0.92
Quantitative analysis of human keratinocyte cell elasticity using atomic force microscopy (AFM). IEEE Trans Nanobioscience (2011) 0.88
Cytokine networks in Pemphigus vulgaris: An integrated viewpoint. Autoimmunity (2012) 0.85
Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J Transl Med (2004) 0.85
BEID: database for sequence-structure-function information on antigen-antibody interactions. Bioinformation (2008) 0.83
Midface and perioral volume restoration: a conversation between the US and Italy. J Drugs Dermatol (2014) 0.83
Reduction in airway complications after lung transplantation with novel anastomotic technique. Ann Thorac Surg (2011) 0.82
High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol (2012) 0.82
The role of T cells in cutaneous autoimmune disease. Autoimmunity (2005) 0.82
Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome. Int J Cancer (2002) 0.81
Utility of the P19 suppressor of gene-silencing protein for production of therapeutic antibodies in Nicotiana expression hosts. Plant Biotechnol J (2012) 0.81
Patterns of use of sunless tanning product alternatives to indoor tanning among female college students. Arch Dermatol (2012) 0.81
Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris. BMC Bioinformatics (2006) 0.81
Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. J Drugs Dermatol (2003) 0.81
Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. J Transl Med (2006) 0.81
Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol (2007) 0.80
Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol (2005) 0.80
T cell targeted immunotherapy for autoimmune disease. Autoimmunity (2005) 0.80
Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. Genomics (2011) 0.80
Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. J Gen Intern Med (2013) 0.78
Comparison of performance on two nonverbal intelligence tests by adolescents with and without language impairment. J Commun Disord (2008) 0.78
NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope. Peptides (2004) 0.78
Atomic force microscopy as nanorobot. Methods Mol Biol (2011) 0.78
Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model. J Invest Dermatol (2012) 0.78
Practical applications of a new botulinum toxin. J Drugs Dermatol (2010) 0.77
Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope. Peptides (2003) 0.77
Immunological hotspots analyzed by docking simulations: evidence for a general mechanism in pemphigus vulgaris pathology and transformation. BMC Immunol (2008) 0.77
Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3. J Exp Ther Oncol (2005) 0.77
Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach. Int J Oncol (2012) 0.77
Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic "hot spots" for differentially expressed genes. Genomics (2012) 0.77
T cell receptor Beta chain gene usage in endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol (2002) 0.77
HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris. Exp Dermatol (2013) 0.77
Efficacy of botulinum neurotoxin type A for treating recalcitrant plaque psoriasis. J Drugs Dermatol (2014) 0.77
A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin (2011) 0.76
Gender differences in alopecia areata. J Drugs Dermatol (2014) 0.76
Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris. Autoimmunity (2012) 0.76
AFP gene expression after acute diethylnitrosamine intoxication is not Afr2 regulated. Cancer Lett (2005) 0.76
Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? J Drugs Dermatol (2011) 0.76
Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med (2006) 0.75
Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression. J Drugs Dermatol (2017) 0.75
A case of argyria: multiple forms of silver ingestion in a patient with comorbid schizoaffective disorder. Cutis (2012) 0.75
Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus. J Drugs Dermatol (2015) 0.75
Lyme disease--part II: clinical features and treatment. Cutis (2002) 0.75
Two men with toxic shock syndrome presenting with targetoid and spotty skin rashes. Acta Derm Venereol (2002) 0.75
Gene therapy in cancer: the missing point. J Exp Ther Oncol (2005) 0.75
Lyme disease--part I: epidemiology and etiology. Cutis (2002) 0.75
Development of a disease registry for autoimmune bullous diseases: initial analysis of the pemphigus vulgaris subset. Acta Derm Venereol (2015) 0.75
Case and discussion of Lyme disease. J Drugs Dermatol (2003) 0.75
Exploring the link between herpes viruses and pemphigus vulgaris: literature review and commentary. Eur J Dermatol (2012) 0.75
Nodules on the arm of a diabetic patient. Arch Dermatol (2003) 0.75
PTPN22 1858T is not a risk factor for North American pemphigus vulgaris. Exp Dermatol (2011) 0.75
Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol (2003) 0.75
Gender-based variability in disease presentation in pemphigus vulgaris. J Drugs Dermatol (2014) 0.75
Rituximab Use in Pediatric Dermatology. J Drugs Dermatol (2016) 0.75
Reproducible Novel Transcriptional Differences Between Psoriatic Lesional and Non-Lesional Skin Show Increased Inflammation and Metabolism. J Drugs Dermatol (2015) 0.75
Darier's disease: a commonly misdiagnosed cutaneous disorder. J Drugs Dermatol (2008) 0.75
Cosmeceutical and nutraceutical horizons. J Drugs Dermatol (2011) 0.75